Bringing a medical device to market requires companies to navigate patent protection, FDA requirements, reimbursement, quality systems and commercialization planning, often at the same time. The central challenge is ensuring that these strategies remain aligned as the product evolves, so that the device a company ultimately brings to market is supported by the appropriate regulatory pathway, reimbursement strategy and intellectual property protection.
In this playbook, Polsinelli attorneys examine 16 key considerations for medical device companies, from early ownership and patent strategy through FDA engagement, reimbursement planning, commercialization and post-launch lifecycle management. The report also includes a strategic timeline highlighting important milestones throughout the development and launch process.
Resources
Read the report
© Polsinelli PC, Polsinelli LLP in California
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | New Biosimilar Legislation Addresses Inflation Reduction Act Delay Provision | 0 | 5.93 | 08-10-2026 |
| 2 | D2R x Lavery | Patenting Your Invention: A Guide for Researchers | 0 | 4.3 | 15-04-2026 |
| 3 | The Reliability Response to Patent Law’s AI Challenges | 0 | 5.75 | 09-09-2026 |
| 4 | FY2026 Patent Data Update: Grants, Publications, and Cross-Border Inventors | 0 | 25.46 | 02-10-2026 |
| 5 | In Support of Collaborative Pediatric Device Innovation | 0 | 5.26 | 01-09-2026 |
| 6 | Owning the Improvement Is Not Freedom to Operate: Exelixis v. MSN Shows the Reach of Earlier Genus Patents | 0 | 8.92 | 07-10-2026 |
| 7 | Wireless Patent Suits Offer Lessons For Data Center Industry | 0 | 6.02 | 24-09-2026 |
| 8 | In Support of Collaborative Pediatric Device Innovation—Reply | 0 | 6.86 | 01-09-2026 |
| 9 | Vein Tech Maker Escapes Suit Over DOJ Kickback Probe | 0 | 9.63 | 23-09-2026 |
| 10 | Fidson Health PLC | 0 | 11.68 | 16-09-2026 |